Brief: Compass Pathways Commends White House Executive Order To Accelerate Research And Access For Psychedelic Treatments
18/04/2026 21:33
April 18 (Reuters) - Compass Pathways PLC CMPS.O: COMPASS PATHWAYS COMMENDS WHITE HOUSE EXECUTIVE ORDER TO ACCELERATE RESEARCH AND ACCESS FOR PSYCHEDELIC TREATMENTS COMPASS PATHWAYS PLC - WELCOMES WHITE HOUSE EXECUTIVE ORDER ON ACCELERATING MEDICAL TREATMENTS COMPASS PATHWAYS PLC - ALREADY WORKING WITH FDA ON ROLLING SUBMISSION FOR COMP360 IN TREATMENT-RESISTANT DEPRESSION Source text: ID:nBw2djbffa Further company coverage: CMPS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on COMPASS Pathways
See all newsBrief: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
UK's Compass Pathways Q1 operating income beats estimates as expenses fall
Health Rounds: Researchers gain new insight into how psychedelics affect the brain
U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications